Literature DB >> 3838935

Purification and properties of carboxypeptidase G2 from Pseudomonas sp. strain RS-16. Use of a novel triazine dye affinity method.

R F Sherwood, R G Melton, S M Alwan, P Hughes.   

Abstract

A folate-degrading enzyme, carboxypeptidase G2, has been purified on a large scale from Pseudomonas sp. strain RS-16. Homogeneous enzyme was obtained by a three-step procedure involving ion-exchange chromatography and a novel triazine dye (affinity) chromatography step which utilizes Zn2+ to promote adsorption of the enzyme. Enzyme was selectively eluted by the use of a chelating agent (EDTA) and a step change in pH. The enzyme is a dimeric protein (Mr 83000) with two identical subunits of 41800 and contains four atoms of zinc per enzyme molecule, which are required for full activity. The enzyme follows Michaelis-Menten kinetics with Km values of 4.0 microM for folate, 8.0 microM for methotrexate and 34.0 microM for 5-methyltetrahydrofolate, the predominant form of reduced folate found in plasma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3838935     DOI: 10.1111/j.1432-1033.1985.tb08860.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  40 in total

1.  Engineering carboxypeptidase G2 circular permutations for the design of an autoinhibited enzyme.

Authors:  Brahm J Yachnin; Sagar D Khare
Journal:  Protein Eng Des Sel       Date:  2017-04-01       Impact factor: 1.650

2.  Case files of the New York City Poison Control Center: antidotal strategies for the management of methotrexate toxicity.

Authors:  Silas W Smith; Lewis S Nelson
Journal:  J Med Toxicol       Date:  2008-06

3.  Inhibition of human folylpolyglutamate synthetase by diastereomeric phosphinic acid mimics of the tetrahedral intermediate.

Authors:  John J McGuire; David M Bartley; John W Tomsho; William H Haile; James K Coward
Journal:  Arch Biochem Biophys       Date:  2009-06-27       Impact factor: 4.013

4.  Crystal structure and mutational analysis of aminoacylhistidine dipeptidase from Vibrio alginolyticus reveal a new architecture of M20 metallopeptidases.

Authors:  Chin-Yuan Chang; Yin-Cheng Hsieh; Ting-Yi Wang; Yi-Chin Chen; Yu-Kuo Wang; Ting-Wei Chiang; Yi-Ju Chen; Cheng-Hsiang Chang; Chun-Jung Chen; Tung-Kung Wu
Journal:  J Biol Chem       Date:  2010-09-06       Impact factor: 5.157

Review 5.  ADEPT and related concepts.

Authors:  K D Bagshawe
Journal:  Cell Biophys       Date:  1994

6.  Analysis of antibody-enzyme conjugate clearance by investigation of prodrug and active drug in an ADEPT clinical study.

Authors:  C J Springer; G K Poon; S K Sharma; K D Bagshawe
Journal:  Cell Biophys       Date:  1994

Review 7.  Antibody-directed enzyme prodrug therapy.

Authors:  K D Bagshawe
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

8.  Identification of prodrug, active drug, and metabolites in an ADEPT clinical study.

Authors:  C J Springer; G K Poon; S K Sharma; K D Bagshawe
Journal:  Cell Biophys       Date:  1993 Jan-Jun

9.  Characterization of poly-gamma-glutamate hydrolase encoded by a bacteriophage genome: possible role in phage infection of Bacillus subtilis encapsulated with poly-gamma-glutamate.

Authors:  Keitarou Kimura; Yoshifumi Itoh
Journal:  Appl Environ Microbiol       Date:  2003-05       Impact factor: 4.792

10.  Characterization of mutations that allow p-aminobenzoyl-glutamate utilization by Escherichia coli.

Authors:  M J Hussein; J M Green; B P Nichols
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.